semaglutide lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Judicial Panel Authorizes New GLP-1

64 WielandKBongersGYamamotoYHashimotoTYamatodaniAMengeWMet al

Brand-name medications (Wegovy, Zepbound) have a list price of approximately $1,000 to $1,300 per month without insurance

Whether it ultimately becomes a major player alongside Retatrutide remains to be seen, but one thing is clear: The era of multi-agonist metabolic peptides and triple-hormone incretin science is just getting started

doi: 10.1038/s41467-022-31963-4 164 SunJSongXWangCRuanQ

The treatment itself was easier than getting blood drawn at a doctors appointment, but Im even more amazed at the results

Metabolism slows, muscle mass naturally decreases, and bone density may decline, making proper nutrition a cornerstone of healthy aging